Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05885035 · ClinicalTrials.gov registry record · Phase 1
Effects of Calcium Hydroxylapatite on Cellulite Dimples in the Buttocks
A Phase 1 study, sponsored by Kalpna Kay Durairaj, MD, FACS.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT05885035 is a Phase 1 study that has completed, run by Kalpna Kay Durairaj, MD, FACS. The registered enrollment target is 25 participants.
The verdict
NCT05885035, a Phase 1 study, has completed, sponsored by Kalpna Kay Durairaj, MD, FACS.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test the efficacy of Calcium Hydroxylapatite (CaHA) in treating cellulite dimples in the buttocks. Participants will: * have 3 treatment sessions at weeks 0, 4, and 8 and a final live assessment visit at week 14 * receive approximately 2 syringes per side of the buttocks, per treatment session * have their pictures taken before and after each treatment session, and once more during the final visit
Interventions
- DRUG Calcium Hydroxyapatite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2023-06-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05885035
The ClinicalTrials.gov registry entry for NCT05885035 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kalpna Kay Durairaj, MD, FACS, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calcium Hydroxyapatite is the first listed.
NCT05885035 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05885035 about?
NCT05885035 is a clinical study titled "Effects of Calcium Hydroxylapatite on Cellulite Dimples in the Buttocks". The goal of this clinical trial is to test the efficacy of Calcium Hydroxylapatite (CaHA) in treating cellulite dimples in the buttocks. Participants will: * have 3 treatment sessions at weeks 0, 4, and 8 and a final live assessment visit at week 14 * receive approximately 2 syringes per side of th...
What is the current status of trial NCT05885035?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2023-01-01. Estimated completion is 2023-06-26.
What interventions are being tested in trial NCT05885035?
The interventions under investigation include: Calcium Hydroxyapatite (DRUG).
Who is sponsoring clinical trial NCT05885035?
This trial is sponsored by Kalpna Kay Durairaj, MD, FACS, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.